Candriam Equities L Biotechnology Class V USD CapRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 31/10/2024 |
|
Annual Returns (GBP) | 31/10/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 31/10 | |
Price Return | 15.80 | -4.52 | 28.75 | 17.60 | -0.68 | 10.01 | 1.62 | 9.28 |
+/- Category | 5.51 | 3.44 | 8.56 | -8.37 | 8.35 | 17.85 | 2.91 | 7.83 |
+/- Category Index | 0.61 | -2.67 | 12.04 | -15.34 | -0.98 | 7.55 | -5.71 | 3.47 |
% Rank in Category | 22 | 31 | 14 | 61 | 34 | 2 | 30 | 12 |
Trailing Returns (GBP) | 21/11/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.46 | -0.24 | 0.68 |
1 Week | -3.43 | 1.27 | -0.13 |
1 Month | -4.26 | 0.52 | 3.47 |
3 Months | -5.01 | -2.09 | 8.61 |
6 Months | 4.82 | 3.98 | 13.76 |
YTD | 6.69 | 7.25 | 5.88 |
1 Year | 22.58 | 7.55 | 15.89 |
3 Years Annualised | 5.70 | 10.32 | 3.80 |
5 Years Annualised | 7.78 | 3.01 | -0.77 |
10 Years Annualised* | 8.68 | 1.56 | 0.42 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 31/10/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.74 | 3.01 | -0.37 | - |
2023 | -5.04 | -0.47 | -0.58 | 8.14 |
2022 | -4.85 | -0.14 | 12.96 | 2.49 |
2021 | -5.69 | 6.93 | 0.73 | -2.22 |
2020 | -4.81 | 25.67 | -5.53 | 4.07 |
2019 | 13.91 | 1.58 | -5.57 | 17.83 |
|
Advertisement |